The First Meeting of the WHO Guideline Development Group for the Revision of the WHO 1999 Guidelines for Iodine Thyroid Blocking.
The meeting held in May 2014 in Würzburg, Germany, discussed the scope of the revision of the 1999 WHO guidelines for iodine thyroid blocking (ITB) by following the WHO handbook for guideline development. This article describes the process and methods of developing the revised, evidence-based WHO guidelines for ITB following nuclear and radiological accidents, the results of the kick-off meeting as well as further steps taken to complete the revision.
University Hospital Wuerzburg, Oberduerrbacher Str. 6, 97080 Wuerzburg, Germany reiners_c@ukw.de.
Christoph
C
Reiners
University Hospital Wuerzburg, Oberduerrbacher Str. 6, 97080 Wuerzburg, Germany.
Rita
R
Schneider
National Institutes for Quantum and Radiological Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, 263-8555 Chiba, Japan.
Makoshi
M
Akashi
Department of Internal Medicine, American University of Beirut, Riad-El-Solh 1107 2020, P.O. Box: 11-0236, Beirut, Lebanon.
Eli A
EA
Akl
Institut de Radioprotection et de Sûreté Nucléaire, B.P. 17, 92262 Fontenay-aux- Roses, France.
Jean-René
JR
Jourdain
Radiation Protection Bureau, Health Canada, 775 Brookfield Rd, Ottawa, Canada K1A 1C1.
Chunsheng
C
Li
Division Radioprotection de l'Office Federal de la Santé Publique, Schwarzenburgstrasse 157, CH-3003 Berne, Switzerland.
Christoph
C
Murith
Federal Agency for Nuclear Control, Ravensteinstraat 36, B-1000 Brussels, Belgium.
Lodewijk
L
Van Bladel
Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
Shunichi
S
Yamashita
Leibniz-Institute for Prevention Research and Epidemiology (BIPS), Achterstraße 30, 28359 Bremen, Germany.
Hajo
H
Zeeb
Endocrine Unit, Department of Clinical and Experimental Medicine, University Hospital, Via Paradisa, 2, 56124 Pisa, Italy.
Paolo
P
Vitti
Department of Public Health, Environmental and Social Determinants of Health, World Health Organization, 20 avenue Appia, 1211 Geneva-27, Switzerland.
Zhanat
Z
Carr
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005062:European Union; D019317:Evidence-Based Medicine; D005260:Female; D062406:Fukushima Nuclear Accident; D017408:Guidelines as Topic; D006291:Health Policy; D006801:Humans; D007223:Infant; D007390:International Agencies; D007457:Iodine Radioisotopes / Q000009:adverse effects*; D007564:Japan; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced / Q000209:etiology / Q000517:prevention & control*; D016273:Occupational Exposure / Q000517:prevention & control; D011193:Potassium Iodide / Q000627:therapeutic use*; D011247:Pregnancy; D011832:Radiation Injuries / Q000517:prevention & control*; D011835:Radiation Protection / Q000379:methods*; D018788:Radioactive Hazard Release; D012196:Review Literature as Topic; D013961:Thyroid Gland / Q000528:radiation effects; D013964:Thyroid Neoplasms / Q000209:etiology / Q000517:prevention & control*; D035862:Vulnerable Populations; D014944:World Health Organization
D007457:Iodine Radioisotopes; D011193:Potassium Iodide